Suppr超能文献

[亲水性药物在中枢神经系统(CNS)分布的动力学分析:基于血脑屏障和血脑脊液屏障转运特性预测CNS分布]

[Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].

作者信息

Suzuki H, Sugiyama Y

机构信息

Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

Yakugaku Zasshi. 1994 Dec;114(12):950-71. doi: 10.1248/yakushi1947.114.12_950.

Abstract

The disposition of hydrophilic drugs in the central nervous system (CNS) was studied in relation to the transport properties across the brain capillaries which form the blood-brain barrier (BBB), and the choroidal epithelial cells which form the blood-cerebrospinal fluid (CSF) barrier, using beta-lactam antibiotics as model compounds. The concentration profiles for cefodizime in the rat CNS were analyzed based on a pharmacokinetic model in which the physiological and anatomical aspects of the CNS were considered. The model analysis revealed that the drug penetration into the CSF after i.v. administration can be accounted for by permeation across the BBB and diffusion through the brain extracellular fluid and across the ependymal surface into the CSF. The drug molecules are eliminated from the CSF by the bulk flow and by the active transport system in the choroid plexus. In in situ and in vivo experiments, we found that the beta-lactam antibiotics are transported across the BBB via a carrier-mediated mechanism. Comparison of kinetic parameters determined in vivo and in vitro experiments revealed (1) that the choroid plexus is the predominant site for the elimination of beta-lactam antibiotics from the CSF and (2) that the isolated choroid plexus can be a useful tool to predict the in vivo elimination clearance. We also found that an anionic exchanger, at least in part, plays a role in the uphill transport of beta-lactam antibiotics in the choroid plexus. Furthermore, the substrate specificity for the anion transporter was examined in the isolated choroid plexus. New quinolones (such as fleroxacin) are also transported by the mechanism shared by beta-lactam antibiotics. Dideoxyinosine, a nucleoside derivative, can be a substrate for the transporter, whereas azidothymidine is recognized, but not transported by the transport system. Transport properties of cimetidine, a prototypic organic cation, in the choroid plexus was also characterized in vivo, in situ and in vitro experiments. An interaction was observed in the transport of cimetidine and that of organic anions. Molecular mechanisms for the CNS transport still remain to be clarified.

摘要

以β-内酰胺类抗生素为模型化合物,研究了亲水性药物在中枢神经系统(CNS)中的分布情况,及其与穿过构成血脑屏障(BBB)的脑毛细血管和构成血脑脊液(CSF)屏障的脉络丛上皮细胞的转运特性之间的关系。基于一个考虑了CNS生理和解剖学方面的药代动力学模型,分析了头孢地嗪在大鼠CNS中的浓度分布情况。模型分析表明,静脉注射给药后药物渗透进入CSF可通过穿过BBB、扩散通过脑细胞外液并穿过室管膜表面进入CSF来解释。药物分子通过脑脊液的大量流动和脉络丛中的主动转运系统从CSF中清除。在原位和体内实验中,我们发现β-内酰胺类抗生素通过载体介导的机制穿过BBB。对体内和体外实验确定的动力学参数进行比较发现:(1)脉络丛是CSF中β-内酰胺类抗生素清除的主要部位;(2)分离的脉络丛可作为预测体内清除率的有用工具。我们还发现,一种阴离子交换剂至少在一定程度上参与了β-内酰胺类抗生素在脉络丛中的上坡转运。此外,在分离的脉络丛中研究了阴离子转运体的底物特异性。新型喹诺酮类药物(如氟罗沙星)也通过β-内酰胺类抗生素共有的机制进行转运。核苷衍生物双脱氧肌苷可作为该转运体的底物,而叠氮胸苷虽能被该转运系统识别,但不能被转运。还通过体内、原位和体外实验对原型有机阳离子西咪替丁在脉络丛中的转运特性进行了表征。观察到西咪替丁和有机阴离子转运之间存在相互作用。CNS转运的分子机制仍有待阐明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验